Radiation-induced thyroid cancer

Thyroid Cancer (Second Edition): A Comprehensive Guide to Clinical Management

Volumn , Issue , 2006, Pages 63-83

  Figge, James J ^a,b   Jennings, Timothy ^c   Gerasimov, Gregory ^d   Kartel, Nikolai ^e   Yarmolinsky, Dima ^e   Ermak, Gennady ^f  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b St Peter's Hospital Albany   (United States)

^c ALBANY MEDICAL CENTER   (United States)

^d N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^e INSTITUTE OF GENETICS AND CYTOLOGY   (Belarus)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953222690     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-995-0_7     Document Type: Chapter

References (208)

1. Hanson GA, Komorowski RA, Cerletty JM, Wilson SD. Thyroid gland morphology in young adults: normal subjects versus those with prior low-dose neck irradiation in childhood. Surgery 1983; 94:984-988.
2. Spitalnik PF, Straus FH. Patterns of human thyroid parenchymal reaction following low-dose childhood irradiation. Cancer 1978; 41: 1098-1105.
3. Freedberg AS, Kurland GS, Blumgart HL. The pathologic effects of I-131 on the normal thyroid gland of man. J Clin Endocrinol 1952; 12:1315-1348.
4. Carr RF, LiVolsi VA. Morphologic changes in the thyroid after irradiation for Hodgkin's and non-Hodgkin's lymphoma. Cancer 1989; 64:825-829.
5. Quimby EH, Werner SC. Late radiation effects in roentgen therapy for hyperthyroidism. JAMA 1949; 140:1046-1047.
6. Winship T, Rosvoll RV. Thyroid carcinoma in childhood: final report on a 20 year study. Clinical Proceedings of the Children's Hospital of Washington, DC 1970; 26:327-349.
7. Roudebush CP, Asteris GT, DeGroot LJ. Natural history of radiation-associated thyroid cancer. Arch Intern Med 1978; 138:1631-1634.
8. Samaan NA, Schultz PN, Ordonez NG, Hickey RC, Johnston DA. A comparison of thyroid carcinoma in those who have and have not had head and neck irradiation in childhood. J Clin Endocrinol Metab 1987; 64:219-223.
9. Mehta MP, Goetowski PG, Kinsella TJ. Radiation induced thyroid neoplasms 1920 to 1987: a vanishing problem? Int J Radial Oncol Biol Phys 1989; 16:1471-1475.
10. Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period. Int J Cancer 1993; 53:183-187.
11. Harach HR, Franssila KO, Wasenius V-M. Occult papillary carcinoma of the thyroid: a "normal" finding in Finland - A systematic autopsy study. Cancer 1985; 56:531-538.
12. Sampson RJ, Woolner LB, Bahn RC, Kurland LT. Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 1974; 34:2072-2076.
13. Wilson SD, Komorowski R, Cerletty J, Majewski JT, Hooper M. Radiation-associated thyroid tumors: extent of operation and pathology technique influence the apparent incidence of carcinoma. S urgery 1983; 94:663-667.
14. Robbins J. Thyroid cancer: a lethal endocrine neoplasm-NIH conference. Ann Intern Med 1991; 115:133-147.
15. Mettler FA, Upton AC. Carcinogenesis at specific sites. In Medical Effects of Ionizing Radiation. Philadelphia, PA: WB Saunders, 1995:130-139.
16. Aldinger KA, Samaan NA, Ibanez M, Hill CS. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer 1978; 41:2267-2275.
17. Duffy BJ, Fitzgerald PJ. Cancer of the thyroid in children: a report of 28 cases. J Clin Endocrinol Metab 1950; 10:1296-1308.
18. Simpson CL, Hempelmann LH. The association of tumors and roentgen-ray treatment of the thorax in infancy. Cancer 1957; 10:42-56.
19. Saenger EL, Silverman FN, Sterling TD, Turner ME. Neoplasia following therapeutic irradiation for benign conditions in childhood. Radiology 1960; 74:889-904.
20. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 1994; 137:817-867.
21. Parker LN, Belsky JL, Yamamoto T, Kawamoto S, Keehn RJ. Thyroid carcinoma after exposure to atomic radiation: a continuing survey of a fixed population, Hiroshima and Nagasaki, 1958-1971. Ann Intern Med 1974; 80:600-604.
22. Schull WJ. Atomic bomb survivors: patterns of cancer risk. Prog Cancer Res Ther 1984; 26:21-36.
23. Fjalling M, Tisell L-E, Carlsson S, Hansson G, Lundberg L-M, Oden A. Benign and malignant thyroid nodules after neck irradiation. Cancer 1986; 58:1219-1224.
24. Furst CJ, Lundell M, Holm LE, Silfversward C. Cancer incidence after radiotherapy for skin hemangioma: a retrospective cohort study in Sweden. J Natl Cancer Inst 1988; 80:1387-1392.
25. Lundell M, Hakulinen T, Holm L-E. Thyroid cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 1994; 140:334-339.
26. Lindberg S, Karlsson P, Arvidsson B, Holmberg E, Lundberg LM, Wallgren A. Cancer incidence after radiotherapy for skin haeman-gioma during infancy. Acia Oncol 1995; 34:735-740.
27. Schneider AB, Ron E, Lubin J, Slovall M, Gierlowski TC. Dose-response relationships for radiation-induced thyroid cancer and nodules: evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 1993; 77:362-369.
28. Schneider AB, Recant W, Pinsky SM, Ryo UY, Bekerman C, Shore-Freedman E. Radiation-induced thyroid carcinoma: clinical course and results of therapy in 296 patients. Ann Intern Med 1986; 105:405-412.
29. Viswanathan K, Gierlowski TC, Schneider AB. Childhood thyroid cancer: characteristics and long-term outcome in children irradiated for benign conditions of the head and neck. Arch Pediatr Adolesc Med 1994; 148:260-265.
30. Schneider AB, Shore-Freedman E, Weinstein RA. Radiation-induced thyroid and other head and neck tumors: occurrence of multiple tumors and analysis of risk factors. J Clin Endocrinol Metab 1986; 63:107-112.
31. Paloyan E, Lawrence AM. Thyroid neoplasms after radiation therapy for adolescent acne vulgaris. Arch Dermatol 1978; 114:53-55.
32. Hempelmann LH, Hall WJ, Phillips M, Cooper RA, Ames WR. Neoplasms in persons treated with X-rays in infancy: fourth survey in 20 years. J Natl Cancer Inst 1975; 55:519-530.
33. Shore RE, Hildreth N, Dvoretsky P, Andresen E, Moseson M, Pasternack B. Thyroid cancer among persons given X-ray treatment in infancy for an enlarged thymus gland. Am J Epidemiol 1993; 137: 1068-1080.
34. Ron E, Modan B, Preston D, Alfandary E, Stovall M, Boice JD. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 1989; 120:516-531.
35. Shore RE, Albert RE, Pasternack BS. Follow-up study of patients treated by X-ray epilation for tinea capitis: resurvey of post-treatment illness and mortality experience. Arch Environ Health 1976; 31:17-24.
36. Ron E, Modan B. Thyroid and other neoplasms following childhood scalp irradiation. Prog Cancer Res Ther 1984; 26:139-151.
37. Tucker MA, Morris Jones PH, Boice JD, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young a ge is linked to secondary thyroid cancer. Cancer Res 1991; 51:2885-2888.
38. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991; 325:599-605.
39. Boice JD, Day NE, Andersen A, Brinton LA, Brown R, Choi NW, et al. Second cancers following radiation treatment for cervical cancer: an international collaboration among cancer registries. J Natl Cancer Inst 1985; 74:955-975.
40. Boice JD, Engholm G, Klienerman RA, Blettner M, Stovall M, Lisco H, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988; 116:3-55.
41. Arai T, Nakano T, Fukuhisa K, Kasamatsu T, Tsunematsu R, Masu-buchi K, et al. Second cancer after radiation therapy for cancer of the uterine cervix. Cancer 1991; 67:398-405.
42. Hay JH, Duncan W, Kerr GR. Subsequent malignancies in patients irradiated for testicular tumours. Br J Radiol 1984; 57:597-602.
43. Fossa SD, Langmark F, Aass N, Andersen A, Lothe R, Borrasen AL. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 1990; 61:639-643.
44. Kendall GM, Muirhead CR, MacGibbon BH, O'Hagan JA, Conquest AJ, Goodill AA, et al. Mortality and occupational exposure to radiation: first analysis of the National Registry for Radiation Workers. BMJ 1992; 304:220-225.
45. Beral V, Inskip H, Fraser P, Booth M, Coleman D, Rose G. Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. BMJ 1985; 291:440-447.
46. Wilkinson GS, Tietjen GL, Wiggs LD, Galke WA, Acquavella JF, Reyes M, et al. Mortality among plutonium and other radiation workers at a plutonium weapons facility. Am J Epidemiol 1987; 125:231-250.
47. Checkoway H, Pearce N, Crawford-Brown DJ, Cragle DL. Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol 1988; 127:255-266.
48. Wing S, Shy CM, Wood JL, Wolf S, Cragle DL, Frame EL. Mortality among workers at Oak Ridge Nationaal Laboratory: evidence of radiation effects in follow-up through 1984. JAMA 1991; 265:1397-1402.
49. Wang J-X, Boice JD, Li B-X, Zhang J-Y, Fraumeni JF. Cancer among medical diagnostic X-ray workers in China. J Natl Cancer Inst 1988; 80:344-350.
50. Boice JD, Mandel JS, Doody MM, Yoder RC, McGowan R. A health survey of radiologic technologists. Cancer 1992; 69:586-598.
51. Smith PG, Doll R. Mortality from cancer and all causes among British radiologists. Br J Radiol 1981; 54:187-194.
52. Mátanosla GM, Seltser R, Sartwell PE, Diamond EL, Elliott EA. The current mortality rates of radiologists and other physician specialists: specific causes of death. Am J Epidemiol 1975; 101:199-210.
53. Stewart A, Kneale GW. Radiation dose effects in relation to obstetric X-rays and childhood cancers. Lancet 1970; 1:1185-1188.
54. Mole RH. Childhood cancer after prenatal exposure to diagnostic X-ray examinations in Britain. Br J Cancer 1990; 62:152-168.
55. Oppenheim BE, Griem ML, Meier P. Effects of low-dose prenatal irradiation in humans: analysis of Chicago Lying-in data and comparison with other studies. Radiat Res 1974; 57:508-544.
56. Harvey EB, Boice JD, Honeyman M, Flannery JT. Prenatal X-ray exposure and childhood cancer in twins. N Engl J Med 1985; 312: 541-545.
57. Rodvall Y, Pershagen G, Hrubec Z, Ahlbom A, Pedersen NL, Boice JD. Prenatal X-ray exposure and childhood cancer in Swedish twins. Int J Cancer 1990; 46:362-365.
58. Yoshimoto Y, Kato H, Schull WJ. Risk of cancer among children exposed in útero to A-bomb radiations, 1950-1984. Lancet 1988; 2:665-669.
59. Lee W, Chiacchierini RP, Shleien B, Telles NC. Thyroid tumors following I-131 or localized X irradiation to the thyroid and pituitary glands in rats. Radiat Res 1982; 92:307-319.
60. Forman D, Cook-Mozaffari P, Darby S, Davey G, Sratton I, Doll R, Pike M. Cancer near nuclear installations. Nature 1987; 329:499-505.
61. Jablon S, Urubec Z, Boice JD. Cancer in populations living near nuclear facilities: a survey of mortality nationwide and incidence in two states. JAMA 1991; 265:1403-1408.
62. Davis S, Kopecky KJ, Hamilton T. Hanford Thyroid Disease Final Report. Seattle, WA: Fred Hutchinson Cancer Research Center, 2002
63. Committee on an Assessment of Centers for Disease Control and Prevention Radiation Studies from DOE Contractor Sites: Subcommittee to Review the Hanford Thyroid Disease Study Final Results and Report, National Academy of Sciences. Review of the Hanford Thyroid Disease Study Draft Final Report. Washington, DC: National Academies Press, 2000.
64. Holm L-E, Wiklund KE, Lundell GE, Bergman NA, Bjelkengren G, Cederquist ES, et al. Thyroid cancer after diagnostic doses of iodine-131: a retrospective cohort study. J Natl Cancer Inst 1988; 80: 1132-1138.
65. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, et al. Cancer mortality following treatment for adult hyperthyroidism. JAMA 1998; 280:347-355.
66. Holm L-E. Malignant disease following iodine-131 therapy in Sweden. Prog Cancer Res Ther 1984; 26:263-271.
67. Hoffman DA, McConahey WM, Fraumeni JF, Kurland LT. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 1982; 11:218-224.
68. Holm L-E, Dahlqvist I, Israelsson A, Lundell G. Malignant thyroid tumors after iodine-131 therapy: a retrospective cohort study. N Engl J Med 1980; 303:188-191.
69. Hoffman DA, McConahey WM, Diamond EL, Kurland LT. Mortality in women treated for hyperthyroidism. Am J Epidemiol 1982; 115:243-254.
70. Goldman MB, Maloof F, Monson RR, Aschengrau A, Cooper DS, Ridgway EC. Radioactive iodine therapy and breast cancer: a follow-up study of hyperthyroid women. Am J Epidemiol 1988; 127: 969-980.
71. Safa AM, Schumacher OP, Rodriguez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine (I-131) for hyperthyroidism. N Engl J Med 1975; 292:167-171.
72. Johnson CJ. Cancer incidence in an area of radioactive fallout downwind from the Nevada test site. JAMA 1984; 251:230-236.
73. Rallison ML, Dobyns BM, Keating PR, Rail JE, Tyler FH. Thyroid disease in children: a survey of subjects potentially exposed to fallout radiation. Am J Med 1974; 56:457-463.
74. Machado SG, Land CE, McKay FW. Cancer mortality and radioactive fallout in southwestern Utah. Am J Epidemiol 1987; 125:44-61.
75. National Cancer Institute. Estimated Exposures and Thyroid Doses Received by the American People from Iodine-131 in Fallout Following Nevada Atmospheric Nuclear Bomb Tests: a Report from the National Cancer Institute. U.S. Department of Health and Human Services, 1997.
76. Gilbert ES, Tarone R, Bouville A, Ron E. Thyroid cancer rates and 131-I doses from Nevada atmospheric nuclear bomb tests. J Natl Cancer Inst 1998; 90:1654-1660
77. Committee on Thyroid Screening Related to I-131 Exposure, Institute of Medicine, and Committee on Exposure of the American People to I-131 from the Nevada Atomic Bomb Tests, National Research Council. Exposure of the American People to Iodine-131 from Nevada Nuclear-Bomb Tests: Review of the National Cancer Institute Report and Public Health Implications. Washington, DC: National Academies Press, 1999.
78. Conard RA, Paglia DE, Larsen PR, Sutow WW, Dobyns BM, Robbins J, et al. Review of medical findings in a Marshallese population twenty-six years after accidental exposure to radioactive fallout. Brookhaven National Laboratory Report 1980; BNL 51261.
79. Conard RA. Late radiation effects in Marshall Islanders exposed to fallout 28 years ago. Prog Cancer Res Ther 1984; 26:57-71.
80. Hamilton TE, van Belle G, LoGerfo JP. Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout. JAMA 1987; 258:629-636.
81. Wiklund K, Holm L-E, Eklund G. Cancer risks in Swedish Lapps who breed reindeer. Am J Epidemiol 1990; 132:1078-1082.
82. Shore RE. Human thyroid cancer induction by ionizing radiation: summary of studies based on external irradiation and radioactive iodines. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Acci dent. Brussels: European Commission, 1996:669-675.
83. Shore RE. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res 1992; 131:98-111.
84. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141:259-277.
85. Shore RE, Woodard E, Hildreth N, Dvoretsky P, Hempelmann L, Pasternack B. Thyroid tumors following thymus irradiation. J Natl Cancer Inst 1985; 74:1177-1184.
86. National Academy of Sciences. Committee on the Biological Effects of Ionizing Radiations: Health Effects of Exposure to Low Level of Ionizing Radiation (BEIR V). Washington, DC: National Academy Press, 1990.
87. Shakhtarin VV, Tsyb AF, Stepanenko VF, Orlov MY, Kopecky KJ, Davis S. Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. Int J Epidemiol 2003; 32:584-591.
88. Niedziela M, Korman E, Breborowicz D, et al. A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster. Pediatr Blood Cancer 2004; 42:84-92.
89. Ron E, Lubin J, Schneider AB. Thyroid cancer incidence. Nature 1992; 360:113.
90. USSR State Committee on the Utilization of Atomic Energy. The Accident at the Chernobyl Nuclear Power Plant and Its Consequences. Information compiled for the International Atomic Energy Agency Experts Meeting, August 25-29, 1986, Vienna. Moscow: USSR State Committee on the Utilization of Atomic Energy, 1986.
91. Travis J. Chernobyl explosion. Inside look confirms more radiation. Science 1994; 263:750.
92. Warman EA. Paper presented at the New York Chapter Health Physics Society symposium on the effects of the nuclear reactor accident at Chernobyl. Upton, NY: Brookhaven National Laboratory, April 3, 1987.
93. Sich AR. Chernobyl thesis. Science 1994; 266:1627-1628.
94. Stone R. The explosions that shook the world. Science 1996; 272:352-354.
95. Sobotovich E, Bondarenko G, Petriaev E. Geochemistry of Chernobyl radionuclides. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:477-483.
96. Izrael YA, De Cort M, Jones AR, et al. The atlas of caesium-137 contamination of Europe after the Chernobyl accident. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:1-10.
97. Balonov M, Jacob P, Likhtarev I, Minenko V. Pathways, levels and trends of population exposure after the Chernobyl accident. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:235-249.
98. Tsaturov YS, De Cort M, Dubois G, Izrael YA, Stukin ED, Fridman SD, et al. The need for standardization in the analysis, sampling and measurement of deposited radionuclides. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996: 425-433.
99. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature 1992; 359:21.
100. World Health Organization. International programme on the health effects of the Chernobyl accident. Geneva: World Health Organization, 1993.
101. Stsjazhko VA, Tsyb AF, Tronko ND, Souchkevitch G, Baverstock KF. Childhood thyroid cancer since accident at Chernobyl. BMJ 1995; 310:801.
102. Williams N, Balter M. Chernobyl research becomes international growth industry. Science 1996; 272:355-356.
103. Balter M. Children become the first victims of fallout. Science 1996; 272:357-360.
104. Goldman M, Catlin R, Anspaugh L. Health and Environmental Consequences of the Chernobyl Nuclear Power Plant Accident. Washington, DC: U.S. Department of Energy Report DOE/ER 0332, 1987.
105. Lange R, Dickerson MH, Gudiksen PH. Dose estimates from the Chernobyl accident. Nucl Technol 1988; 82:311-323.
106. Nauman J, Wolff J. Iodine prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am J Med 1993; 94:524-532.
107. Dubina YV, Schekin YK, Guskina LN. Systematisation and verification of the spectrometrical analysis data of soil, grass, milk and milk products samples with results of 131-iodine measurements. (In Russian) Minsk, Belarus, 1990.
108. Becker DV, Robbins J, Beebe GW, Bouville AC, Wachholz BW. Childhood thyroid cancer following the Chernobyl accident. Endocrinol Metab Clin North Am 1996; 25:197-211.
109. Mityukova T, Astakhova L, Asenchyk L, Orlov M, Van Middlesworth L. Urinary iodine excretion in Belarus children. Eur J Endocrinol 1995; 133:216-217.
110. Gerasimov G, Alexandrova G, Arbuzova M, Butrova S, Kenzhibaeva M, Kotova G, et al. Iodine defficiency disorders (IDD) in regions of Russia affected by Chernobyl. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996: 813-815.
111. Gavrilin Y, Khrouch V, Shinkarev S, Drozdovitch V, Minenko V, Shemyakina E, et al. Estimation of thyroid doses received by the population of Belarus as a result of the Chernobyl accident. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:1011-1020.
112. Jacob P, Kenigsberg Y, Zvonova I, Goulko G, Buglova E, Heidenreich WF, et al. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br J Cancer 1999; 80:1461-1469.
113. Gavrilin YI, Gordeev KI, Ivanov VK, Ilyin LA, Kondrusev AI, Margulis UY, et al. The process and results of the reconstruction of internal thyroid doses for the population of contaminated areas of the Republic of Belarus. (In Russian) Vestn Acad Med Sci 1992; 2:35-43.
114. Ilyin LA, Balonov MI, Buldakov LA, et al. Radiocontamination patterns and possible health consequences of the accident at the Chernobyl nuclear power station. J Radiol Prot 1990; 10:13-29.
115. Gavrilin YI, Gordeev KI, Ilyin LA, et al. Results of thyroid dose assessment for contaminated territories of Belarussia. (In Russian) Bull Acad Med Sci USSR 1991; 8:35.
116. Gavrilin YI, Khrouch VT, Shinkarev SM. Internal thyroid exposure of the residents in several contaminated areas of Belarus. (In Russian) J Med Radiol 1993; 6:15-20.
117. Khrouch VT, Gavrilin YI, Shinkarev SM, et al. Generalization of results of individual thyroid dose reconstruction: determination of connections between parameters of contamination of people residences and levels of irradiation on thyroid glands. (In Russian) Minsk, Belarus, Moscow: Final Report of Institute of Biophysics, Moscow Contract N 7-17/93 with the Ministry of Public Health, 1994.
118. Stepanenko V, Gavrilin Y, Khrousch V, et al. The reconstruction of thyroid dose following Chernobyl. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996: 937-948.
119. Tsyb AF, Parshkov EM, Shakhtarin VV, Stepanenko VF, Skvortsov VF, Chebotareva I V. Thyroid cancer in children and adolescents of Bryansk and Kaluga regions. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996: 691-697.
120. Zvonova I, Balonov MI. Radioiodine dosimetry and prediction of thyroid effects on inhabitants of Russia following the Chernobyl accident. In Merwin SE, Balonov MI, editors. The Chernobyl Papers, vol. I: Doses to the Soviet Population and Early Health Effects Studies. Richland, WA: Research Enterprises, 1993:71-126.
121. Sobolev B, Likhtarev I, Kairo I, Tronko N, Oleynik V, Bogdanova T. Radiation risk assessment of the thyroid cancer in Ukrainian children exposed due to Chernobyl. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996: 741-748.
122. Likhtarev IA, Sobolev BG, Kairo IA, Tronko ND, Bogdanova TI, Oleinic VA, et al. Thyroid cancer in the Ukraine. Nature 1995; 375: 365.
123. Likhtarev IA, Shandala NK, Gulko GM, Kairo IA, Chepurny NI. Ukrainian thyroid doses after the Chernobyl accident. Health Phys 1993; 64:594-599.
124. Likhtarev I, Sobolev B, Kairo I, et al. Results of large scale thyroid dose reconstruction in Ukraine. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996: 1021-1034.
125. Likhtarev IA, Gulko GM, Sobolev BG, et al. Thyroid dose assessment for the Cherginov region (Ukraine): estimation based on 131I thyroid measurements and extrapolation of the results to districts without monitoring. Radiat Environ Biophys 1994; 33:149-166.
126. Prisyazhiuk A, Pjatak OA, Buzanov VA, Reeves GK, Beral V. Cancer in the Ukraine, post-Chernobyl. Lancet 1991; 338:1334-1335.
127. Oleynic VA, Cheban AK. Thyroid cancer in children of Ukraine from 1981 to 1992. In Robbins J, editor. Treatment of Thyroid Cancer in Childhood. Proceedings of a workshop on September 10-11, 1992, at the National Institutes of Health. Publication No. DOE/EH-0406 1992; 35.
128. Astakhova LN. Condition of the thyroid system and peculiarity of forming its pathology in the BSSR population under influence of the iodine-radionuclides in connection with Chernobyl nuclear accident. (In Russian) Zdravoohranenie Belorussi 1990; 6:11-15.
129. Astakhova LN, Demidchuk EP, Davydova EV, et al. Health status of Byelorussian children and adolescents exposed to radiation as consequence of the Chernobyl atomic energy station accident. (In Russian) Vestn Akad Med Nauk USSR 1991; 11:25-27.
130. Okeanov AE, Averkin YI. Analysis of malignant neoplasms in population of the Republic of Belarus before and after the Chernobyl accident. In Matyukhin VA, Astakhova LN, Konigsberg YE, Nalivko SN, editors. Catastrophe at the Chernobyl Atomic Energy Station and Estimation of Health State of Population of the Republic of Belarus. Minsk: Research Institute of Radiation Medicine, 1991:25-33.
131. Astakhova LN, Vorontsova TV, Drozd VM. Thyroid nodule pathology in children of Belarus following the Chernobyl accident. In Robbins J, editor. Treatment of Thyroid Cancer in Childhood. Proceedings of a workshop on September 10-11, 1992, at the National Institutes of Health. Publication No. DOE/EH-0406 1992; 35.
132. Baverstock K, Egloff B, Finchera A, Ruchti C, Williams D. Thyroid cancer after Chernobyl. Nature 1992; 359:21-22.
133. Demidchik EP, Kazakov VS, Astakhova LN, et al. Thyroid cancer in children after the Chernobyl accident: clinical and epidemiological evaluation of 251 cases in the Republic of Belarus. In Nagataki S, editor. Nagasaki Symposium on Chernobyl: Update and Future. Amsterdam: Elsevier, 1994:21.
134. Demidchik EP, Drobyshevskaya IM, Cherstvoy ED, et al. Thyroid cancer in children in Belarus. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:677-682.
135. Abelin T, Averkin JI, Egger M, et al. Thyroid cancer in Belarus post-Chernobyl: improved detection or increased incidence? Soz Praventiv-med 1994; 39:189-197.
136. Averkin JI, Abelin T, Bleuer JP. Thyroid cancer in children in Belarus: ascertainment bias? Lancet 1995; 346:1223-1224.
137. Abelin T, Egger M, Ruchti C. Belarus increase was probably caused by Chernobyl. BMJ 1994; 309:1298.
138. Williams ED, Cherstvoy E, Egloff B, et al. Interaction of pathology and molecular characterization of thyroid cancers. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:699-714.
139. Abelin T, Averkin JI, Okeanov AE, Bleuer JP. Thyroid cancer in Belarus: the epidemiologic situation. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:727-730.
140. Malko M. Chernobyl radiation induced thyroid cancers in Belarus. Joint Institute of Power and Nuclear Research, National Academy of Science of Belarus, pp. 240-255. Ava ilable on: www-j.rri.kyoto-u.ac.jp/NSRG/reports/kr79/kr79pdf/ Malko2.pdf.
141. Demidchik YE, Demidchik EP. Thyroid carcinomas in Belarus 16 years after the Chernobyl disaster. In Proceedings of Symposium of Chernobyl-Related Health Effects. Tokyo, Japan: Radiation Effects Association, 2002.
142. Tsyb AF, Parshkov EM, Ivanov VK, Stepanenko VF, Matveenko EG, Skoropad YD. Disease indices of thyroid and their dose dependence in children and adolescents affected as a result of the Chernobyl accident. In Nagataki S, editor. Amsterdam: Elsevier Science, 1994:9-19.
143. Remennik LV, Starinsky VV, Mokina VD, et al. Malignant neoplasms on the territories of Russia damaged owing to the Chernobyl accident. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:825-828.
144. Tronko N, Bogdanova T, Komissarenko I, et al. Thyroid cancer in children and adolescents in Ukraine after the Chernobyl accident. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996: 683-690.
145. Tronko N, Epstein Y, Oleinik V, et al. Thyroid gland in children after the Chernobyl accident (yesterday and today). In Nagataki S, editor. Nagasaki symposium on Chernobyl: update and future. Amsterdam: Elsevier, 1994:31-46.
146. Williams ED, Tronko ND. Molecular, Cellular, Biological Characterization of Childhood Thyroid Cancer. Brussels: European Commission, 1996.
147. Cherstvoy E, Pozcharskaya V, Harach HR, Thomas GA, Williams ED. The pathology of childhood thyroid carcinoma in Belarus. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:779-784.
148. Bogdanova T, Bragarnik M, Tronko ND, Harach HR, Thomas GA, William ED. The pathology of thyroid cancer in Ukraine post Chernobyl. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:785-789.
149. Abrosimov AY, Lushnikov EF, Tsyb AF, Harach HR, Thomas GA, Williams ED. The pathology of childhood thyroid tumours in the Russian Federation after Chernobyl. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:791-793.
150. Furmanchuk AW, Averkin JI, Egloff B, et al. Pathomorphological findings in thyroid cancers of children from the Republic of Belarus: a study of 86 cases occurring between 1986 ("post-Chernobyl") and 1991. Histopathology 1992; 21:401-408.
151. Nikiforov Y, Gnepp DR. Pediatric thyroid cancer after the Chernobyl disaster. Cancer 1994; 74:748-766.
152. Williams ED. Thyroid cancer in United Kingdom children and in children exposed to fallout from Chernobyl. In Nagataki S, editor. Nagasaki symposium on Chernobyl: update and future. Tokyo, Japan: Elsevier, 1994.
153. Nikiforov Y, Gnepp DR, Fagin JA. Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 1996; 81:9-14.
154. Pacini F, Vorontsova T, Demidchik EP, et al. D iagnosis, surgical treatment and follow-up of thyroid cancers. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996: 755-763.
155. Nikiforov YE, Heffess CS, Korzenko AV, Fagin JA, Gnepp DR. Characteristics of follicular tumors and nonneoplastic thyroid lesions in children and adolescents exposed to radiation as a result of the Chernobyl disaster. Cancer 1995; 76:900-909.
156. Sierk AE, Askin FB, Reddick RL, Thomas CG. Pediatric thyroid cancer. Pediatr Pathol 1990; 10:877-893.
157. Harness JK, Thompson NW, Nishiyama RH. Childhood thyroid carcinoma. Arch Surg 1971; 102:278-284.
158. Richardson JE, Beaugie JM, Brown CL, Doniach I. Thyroid cancer in young patients in Great Britain. Br J Surg 1974; 61:85-89.
159. Tallroth E, Backdahl M, Einhorn J, Lundell G, Lowhagen T, Silfversward C. Thyroid carcinoma in children and adolescents. Cancer 1986; 58:2329-2332.
160. Mizukami Y, Michigishi T, Nonomura A, et al. Carcinoma of the thyroid at young age: a review of 23 patients. Histopathology 1992; 20:63-66.
161. Robbins J. Characteristics of spontaneous and radiation induced thyroid cancers in children. In Nagataki S, editor. Nagasaki Symposium on Chernobyl: Update and Future. Amsterdam: Elsevier, 1994:81.
162. Williams ED. Radiation-induced thyroid cancer. Histopathology 1993; 23:387-389.
163. Willams ED. Chernobyl, eight years on. Nature 1994; 371:556.
164. Williams D. Thyroid cancer and the Chernobyl accident. J Clin Endocrinol Metab 1996; 81:6-8.
165. Ito T, Seyama T, Iwamoto KS, Mizuno T, Tronko ND, Komissarenko IV, et al. Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident. Lancet 1994; 344:259.
166. Fugazzola L, Pilotti S, Pinchera A, et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 1995; 55:5617-5620.
167. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 1997; 57:1690-1694.
168. Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 1995; 11:2459-2467.
169. Rabes HM, Klugbauer S. Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement. (German) Verh Dtsch Ges Pathol 1997; 81:139-144.
170. Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM. A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident. Oncogene 1996; 13:1099-1102.
171. Klugbauer S, Demidchik EP, Lengfelder E, Rabes HM. Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl. Oncogene 1998; 16:671-675.
172. Fugazzola L, Pierotti M, Vigano E, Pacini F, Verontsova T, Bongarzone I. Molecular and biochemical analysis of RET/PTC4, a novel oncogeneic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene 1996; 13: 1093-1097.
173. Klugbauer S, Demidchik EP, Lengfelder E, Rabes HM. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5. Cancer Res 1998; 58:198-203.
174. Klugbauer S, Rabes HM. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 1999; 18: 4388-93.
175. Salassidis K, Bruch J, Zitzelsberger H, Lengfelder E, Kellerer AM, Bauchinger M. Translocation t(10;14)(q11.2:q22.1) fusing the kinectin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma. Cancer Res 2000; 60:2786-2789.
176. Klugbauer S, Jauch A, Lengfelder E, Demidchik E, Rabes HM. A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8). Cancer Res 2000; 60:7028-7032.
177. Rabes HM, Demidchik EP, Sidorow JD, et al. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin Cancer Res 2000; 6:1093-1103.
178. Rabes HM. Gene rearrangements in radiation-induced thyroid car-cinogenesis. Med Pediatr Oncol 2001; 36:574-582.
179. Pisarchik AV, Ermak G, Fomicheva V, Kartel NA, Figge J. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus. Thyroid 1998; 8:133-139.
180. Pisarchik AV, Ermak G, Demidchik EP, Mikhalevich LS, Kartel NA, Figge J. Low prevalence of the ret/PTC3r1 rearrangement in a series of papillary thyroid carcinomas presenting in Belarus ten year post-Chernobyl. Thyroid 1998; 8:1003-1008.
181. Pisarchik AV, Yarmolinskii DG, Demidchik YE, Ermak GZ, Kartel NA, Figge J. ret/PTC1 and ret/PTC3r1 rearrangement in thyroid cancer cells, arising in residents of Belarus in the period after the accident at the Chernobyl nuclear power plant. (In Russian) Genetika 2000; 36:959-964.
182. Smida J, Salassidis K, Hieber L, et al. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int J Cancer 1999; 80:32-38.
183. Thomas GA, Bunnell H, Cook HA, et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 1999; 84:4232-4238.
184. Santoro M, Thomas GA, Vecchio G, et al. Gene rearrangement and Chernobyl related thyroid cancers. Br J Cancer. 2000; 82:315-322.
185. Williams ED, Abrosimov A, Bogdanova T, et al. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer 2004; 90:2219-2224.
186. Elisei R, Romei C, Vorontsova T, et al. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 2001; 86:3211-3216.
187. Jhiang SM, Sagartz JE, Tong Q, et al. Ta r geted expression of the RET/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 1996; 137:375-378.
188. Santoro M, Chiappetta G, Cerrato A, et al. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 1996; 12: 1821-1826.
189. Powell DJ Jr, Russell J, Nibu K, et al. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res 1998; 58:5523-5528.
190. Ito T, Seyama T, Iwamoto KS, et al. In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res 1993; 53:2940-2943.
191. Bounacer A, Wicker R, Caillou B, et al. H igh prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 1997; 15:1263-1273.
192. Collins BJ, Chiappetta G, Schneider AB, et al. RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab 2002; 87:3941-3946.
193. Butti MG, Bongarzone I, Ferraresi G, Mondellini P, Borrello MG, Pierotti MA. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas. Genomics 1995; 28:15-24.
194. Beimfohr C, Klugbauer S, Demidchik EP, Lengfelder E, Rabes HM. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident. Int J Cancer. 1999; 80:842-847.
195. Nikiforov YE, Nikiforova MN, Gnepp DR, Fagin JA. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene 1996; 13:687-693.
196. Hillebrandt S, Streffer C, Reiners C, Demidchik E. Mutations in the p53 tumor suppressor gene in thyroid tumors of children from areas contaminated by the Chernobyl accident. Int J Radial Biol 1996; 69:39-45.
197. Hillebrandt S, Streffer C, Demidchik EP, Biko J, Reiners C. Polymorphisms in the p53 gene in thyroid tumors and blood samples of children from areas in Belarus. Mutat Res 1997; 381:201-207.
198. Smida J, Zitzelsberger H, Kellerer AM, et al. P53 mutations in childhood thyroid tumors from Belarus and in thyroid tumors without radiation history. Int J Cancer 1997; 73:802-807.
199. Suchy B, Waldmann V, Klugbauer S, Rabes HM. Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumors. Br J Cancer 1998; 77:952-955.
200. Pisarchik AV, Ermak G, Kartel NA, Figge J. Molecular alterations involving p53 codons 167 and 183 in papillary thyroid carcinomas from Chernobyl-contaminated regions of Belarus. Thyroid 2000; 10:25-30.
201. Beral V, Reeves G. Childhood thyroid cancer in Belarus. Nature 1992; 359:680-681.
202. Shigematsu I, Thiessen JW. Childhood thyroid cancer in Belarus. Nature 1992; 359:681.
203. Beebe GW. Epidemiologic studies of thyroid cancer in the CIS. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996:731-740.
204. Astakhova LN, Anspaugh LR, Beebe GW, Bouville A, Drozdovitch VV, Garber V, et al. Chernobyl-related thyroid cancer in children of Belarus: a case-control study. Radiat Res 1998; 150:349-356.
205. Jacob P, Goulko G, Heidenreich WF, et al. Thyroid cancer risk to children calculated. Nature 1998; 392:31-32.
206. Shibata Y, Yamashita S, Masyakin VB, Panasyuk GD, Nagataki S. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet 2001; 358:1965-1966.
207. Robbins J, Dunn JT, Bouville A, et al. Iodine nutrition and the risk from radioactive iodine: a workshop report in the Chernobyl long-term follow-up study. Thyroid 2001; 11:487-491.
208. Cardis E, Okeanov AE. What is feasible and desirable in the epi-demiologic follow-up of Chernobyl. In Karaoglou A, Desmet G, Kelly GN, Menzel HG, editors. The Radiological Consequences of the Chernobyl Accident. Brussels: European Commission, 1996: 835-850.